CS
SLDB icon

Credit Suisse’s Solid Biosciences SLDB Stock Holding History

Credit Suisse’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2
Closed – – 4258
2022
Q2 		$0 Buy
+2
New +$21 ﹤0.01% 4273
2020
Q2 		– Sell
-1,038
Closed -$37K – 4120
2020
Q1 		$37K Buy
1,038
+32
+3% +$1.58K ﹤0.01% 3920
2019
Q4 		$67K Buy
1,006
+273
+37% +$30.1K ﹤0.01% 4092
2019
Q3 		$114K Buy
+733
New +$82.9K ﹤0.01% 3956
2019
Q2 		– Sell
-2,105
Closed -$290K – 4225
2019
Q1 		$290K Buy
2,105
+1,547
+277% +$388K ﹤0.01% 3611
2018
Q4 		$224K Buy
+558
New +$262K ﹤0.01% 3631

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Credit Suisse's SLDB Position: Q3 2022 in Review

Credit Suisse sold out of Solid Biosciences (SLDB) in Q3 2022, closing a stake of 2 shares.

Credit Suisse first reported a position in SLDB in Q4 2018 and held it in 6 quarters. The position peaked at $290K in Q1 2019. 58 funds tracked by Wall St. Rank hold SLDB as of Q3 2022.

  • Credit Suisse reported no remaining Solid Biosciences position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 2 Solid Biosciences shares in Q3 2022.
  • Credit Suisse first reported a position in Solid Biosciences in Q4 2018 and held it in 6 quarters.
  • Credit Suisse's Solid Biosciences position peaked at $290K in Q1 2019.
  • 58 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.